AbbVie Inc. (ABBV) DCF Valuation

AbbVie Inc. (ABBV) DCF Valuation

US | Healthcare | Drug Manufacturers - General | NYSE
AbbVie Inc. (ABBV) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

AbbVie Inc. (ABBV) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover the true value of AbbVie Inc. (ABBV) with our advanced DCF Calculator! Adjust essential assumptions, explore various scenarios, and evaluate how changes affect AbbVie Inc. (ABBV) valuation – all within a convenient Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 33,266.0 45,804.0 56,197.0 58,054.0 54,318.0 62,092.2 70,979.0 81,137.8 92,750.5 106,025.2
Revenue Growth, % 0 37.69 22.69 3.3 -6.44 14.31 14.31 14.31 14.31 14.31
EBITDA 16,264.0 21,148.0 28,280.0 31,424.0 17,308.0 28,733.5 32,845.9 37,546.9 42,920.7 49,063.7
EBITDA, % 48.89 46.17 50.32 54.13 31.86 46.28 46.28 46.28 46.28 46.28
Depreciation 2,017.0 6,471.0 8,521.0 8,467.0 8,698.0 8,190.1 9,362.3 10,702.3 12,234.0 13,985.0
Depreciation, % 6.06 14.13 15.16 14.58 16.01 13.19 13.19 13.19 13.19 13.19
EBIT 14,247.0 14,677.0 19,759.0 22,957.0 8,610.0 20,543.3 23,483.6 26,844.6 30,686.7 35,078.7
EBIT, % 42.83 32.04 35.16 39.54 15.85 33.09 33.09 33.09 33.09 33.09
Total Cash 39,924.0 8,479.0 9,830.0 9,229.0 12,816.0 21,793.8 24,913.0 28,478.6 32,554.5 37,213.8
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 5,428.0 8,822.0 9,977.0 11,254.0 11,155.0
Account Receivables, % 16.32 19.26 17.75 19.39 20.54
Inventories 1,813.0 3,310.0 3,128.0 3,579.0 4,099.0 3,968.2 4,536.1 5,185.3 5,927.5 6,775.8
Inventories, % 5.45 7.23 5.57 6.16 7.55 6.39 6.39 6.39 6.39 6.39
Accounts Payable 1,452.0 2,276.0 2,882.0 2,934.0 3,688.0 3,266.8 3,734.3 4,268.8 4,879.7 5,578.2
Accounts Payable, % 4.36 4.97 5.13 5.05 6.79 5.26 5.26 5.26 5.26 5.26
Capital Expenditure -552.0 -798.0 -787.0 -695.0 -777.0 -922.6 -1,054.7 -1,205.6 -1,378.2 -1,575.5
Capital Expenditure, % -1.66 -1.74 -1.4 -1.2 -1.43 -1.49 -1.49 -1.49 -1.49 -1.49
Tax Rate, % 22.19 22.19 22.19 22.19 22.19 22.19 22.19 22.19 22.19 22.19
EBITAT 13,327.2 19,937.9 17,557.8 20,161.7 6,699.3 18,408.3 21,042.9 24,054.7 27,497.5 31,433.0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 9,003.2 21,543.9 24,924.8 26,257.7 14,953.3 24,959.8 27,592.7 31,541.9 36,056.3 41,216.8
WACC, % 6.84 6.89 6.81 6.8 6.73 6.81 6.81 6.81 6.81 6.81
PV UFCF
SUM PV UFCF 130,785.4
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) 42,659
Terminal Value 1,288,054
Present Terminal Value 926,479
Enterprise Value 1,057,264
Net Debt 46,571
Equity Value 1,010,693
Diluted Shares Outstanding, MM 1,773
Equity Value Per Share 570.05

What You Will Receive

  • Real AbbVie Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
  • Complete Customization: Modify all essential parameters (yellow cells) like WACC, growth %, and tax rates.
  • Instant Valuation Updates: Automatic recalculations to evaluate the impact of changes on AbbVie's fair value.
  • Flexible Excel Template: Designed for quick edits, scenario analysis, and comprehensive projections.
  • Time-Efficient and Precise: Avoid building models from the ground up while ensuring accuracy and adaptability.

Key Features

  • Real-Life ABBV Data: Pre-filled with AbbVie’s historical financials and forward-looking projections.
  • Fully Customizable Inputs: Adjust revenue growth, margins, WACC, tax rates, and capital expenditures.
  • Dynamic Valuation Model: Automatic updates to Net Present Value (NPV) and intrinsic value based on your inputs.
  • Scenario Testing: Create multiple forecast scenarios to analyze different valuation outcomes.
  • User-Friendly Design: Simple, structured, and designed for professionals and beginners alike.

How It Works

  • Step 1: Download the prebuilt Excel template with AbbVie Inc.'s (ABBV) data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including AbbVie Inc.'s (ABBV) intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator for AbbVie Inc. (ABBV)?

  • Comprehensive Tool: Features DCF, WACC, and financial ratio analyses tailored for AbbVie Inc. (ABBV).
  • Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
  • Detailed Insights: Automatically calculates AbbVie Inc. (ABBV)’s intrinsic value and Net Present Value.
  • Preloaded Data: Historical and projected data provide reliable starting points for analysis.
  • Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on AbbVie Inc. (ABBV).

Who Should Use This Product?

  • Investors: Accurately assess AbbVie's fair value prior to making investment choices.
  • CFOs: Utilize a professional-grade DCF model for precise financial reporting and analysis.
  • Consultants: Efficiently modify the template for client valuation reports.
  • Entrepreneurs: Discover insights into financial modeling practices employed by leading pharmaceutical companies.
  • Educators: Implement it as a teaching resource to illustrate valuation techniques.

What the Template Contains

  • Preloaded ABBV Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.